Analyst consensus rating
Treace Medical Concepts Analyst Rating: none
TMCI is rated none by 3 analysts with a $5.50 target. As of 2026-09-02.
Direct answer
Treace Medical Concepts's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.50.
Forecast evidence checked September 2, 2026.
Get free Treace Medical Concepts email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.60
- Average price target
- $5.50
- High price target
- $7.00
- Low price target
- $4.50
- Low target gap
- -2.2%
- Target upside
- +19.6%
- High target gap
- +52.2%
- Target range width
- 54.3%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Treace Medical Concepts?
Treace Medical Concepts has a verified none consensus. The same dataset has an average price target of $5.50.
How far are Treace Medical Concepts's low and high targets from the recorded price?
The low target implies -2.2%, while the high target implies +52.2%.
How many analysts are included in Treace Medical Concepts's consensus?
The verified consensus includes 3 analysts.
How is Treace Medical Concepts's target upside or downside calculated?
The average target of $5.50 is divided by the recorded price of $4.60, then one is subtracted to produce +19.6%. This does not guarantee a future return.
When was Treace Medical Concepts's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.